Human Organoids Market to Grow with a CAGR of 4.19% through 2031

Surge in research and development activities is expected to drive the Global Human Organoids Market growth in the forecast period, 2027-2031.

According to TechSci Research's report, “Human Organoids Market - Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2031F,” the global human organoids market is projected to grow from USD 512.24 million in 2025 to USD 655.28 million by 2031, at a 4.19% CAGR. Government initiatives based on human organoids have led to favourable market conditions for the Global Human Organoids Market. Several factors contribute to the growth of various human organoid products.

Pharmaceutical companies are at the forefront of leveraging human organoids for drug discovery and preclinical testing. Organoids provide a more accurate and efficient model for predicting how human tissues and organs will respond to drugs, reducing reliance on animal testing, which often fails to replicate human-specific responses. This surge in R&D is shortening drug development timelines, allowing for faster identification of viable drug candidates, and improving the safety and efficacy of new treatments. With increasing demand for more precise, patient-specific drugs, organoids are becoming a crucial tool in personalized medicine, thereby driving market expansion.

Governments are providing significant financial support to foster research and development (R&D) in human organoids. National funding agencies, such as the National Institutes of Health (NIH) in the U.S. and Horizon Europe, have been instrumental in financing organoid research projects. These funds support studies that use organoids for disease modeling, drug discovery, and regenerative medicine. Such investments are crucial for accelerating advances in organoid technology and its applications across sectors such as healthcare and pharmaceuticals.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Human Organoids Market”

The Global Human Organoids Market is segmented by source, organ type, region, and company.

Based on Source, Induced Pluripotent Stem Cells have emerged as the dominating segment in the Global Human Organoids Market in 2024. One of the key factors contributing to the rise of iPSCs is their ability to create organoids that closely resemble human tissue at both structural and functional levels. iPSC-derived organoids have become essential tools for studying human development, modeling diseases, and testing new drug therapies. Their ability to differentiate into multiple cell types enables researchers to generate a wide range of tissues, including those of the brain, heart, liver, and lungs. This capability makes iPSCs indispensable for advancing research across numerous medical fields, including oncology, neurology, and regenerative medicine, further solidifying their dominant position in the organoid market.

Based on Region, Asia Pacific have emerged as the fastest growing region in the Global Human Organoids Market in 2024. Rapidly growing healthcare infrastructure across the region is supporting the development of advanced medical research facilities. Governments and private institutions are investing heavily in state-of-the-art research centers and laboratories to foster the development of organoid technologies for drug testing and regenerative medicine.

Major companies operating in Global Human Organoids Market are:

• American Type Culture Collection (ATCC)
• Thermo Fisher Scientific Inc.
• STEMCELL Technologies Canada Inc.
• Merck KGaA
• Corning Incorporated
• Bio-Techne Corporation
• ACROBIOSYSTEMS INC.
• AMS Biotechnology (Europe) Ltd
• Qkine Ltd.
• PRIMACYT Cell Culture Technology GmbH

Download Free Sample Report

Customers can also request for 10% free customization on this report

“Nanotechnology has been instrumental in improving the creation and structural integrity of human organoids. By utilizing nanomaterials, scientists can create scaffolds that more closely mimic the natural extracellular matrix (ECM) of human tissues. These nano-engineered scaffolds provide a supportive environment for the growth of organoids, promoting better cell differentiation and organisation, thus resulting in more complex and physiologically relevant models”, said Mr Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Human Organoids Market - Global Industry Size, Share, Trends, Opportunities and Forecast, Segmented By Source (Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells, Others), By Organ Type (Stomach Models, Intestine Models, Liver Models, Pancreatic Models, Lung Models, Brain Models, Kidney Models, Others), By Region and Competition, 2021-2031F”, has evaluated the future growth potential of Global Human Organoids Market and provides statistics & information on market size, structure, and future market growth. The report aims to provide cutting-edge market intelligence and help decision-makers make sound investment decisions. Besides, the report also identifies and analyses the emerging trends along with essential drivers, challenges, and opportunities in the Global Human Organoids Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]